KRX •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 08/21/2026
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeKRX
Market Capitalization97,872 mln
Float107 mln
Piotroski F-Score
1
/ 9
Very weak
Beneish M-Score
-2.45
Borderline
Relative Strength
2
/ 100
Severely lagging
Debt / Equity
0.44
Low leverage
ROE
-4.22
Negative
Dividend Yield
0.00%
No dividend
Business Description
Founded in 2001 and based in Seoul, South Korea, CMG Pharmaceutical Co. Ltd. specializes in developing and selling medicines that dissolve in the mouth, known as oral thin films. The company's products address a range of conditions, including erectile dysfunction, hepatitis B, schizophrenia, asthma, and allergic rhinitis. CMG Pharmaceutical also works alongside Handok Inc. under a partnership focused on cancer treatment.
